REAL-TIME GLOBAL RESEARCH
European Chemicals: Weekend Chemical Reactions
Research evidence excerpt
J P M O R G A N
Europe Equity Research
16 August 2026
European Chemicals
Weekend Chemical Reactions
What’s in the Note? Click on the section title below to jump to that section:
European Chemicals
Chetan Udeshi, CFA AC
Trending Over the Past Week
What Caught Our Eye?
(44-20) 7742-7034
J.P. Morgan Securities plc
Key Upcoming Events
Angelina Glazova, CFA AC
Weekly Recap: Key Insights from JPM Research
(44-20) 7134-8379
J.P. Morgan Securities plc
Sector Valuation
Kanchan Sangtani
Trending Over the Past Week
(91-22) 6157-3639
J.P. Morgan India Private Limited
Here, we discuss the stocks/topics where we have seen the most incremental client
interest and feedback over the past week.
Specialist Sales contact details:
(44-20) 7742-8733
Syensqo (SYENS): We reiterated OW in our note: “Syensqo: SOTP catalyst
meets Polymers recovery – raising PT to €100”. The key pushbacks were:
Too early to call a Specialty Polymers inflection based on just 2Q
improvement, especially given demand distortions (e.g., customer prebuying) tied to the Middle East conflict. JPM view: The concern is
reasonable, but we are encouraged by management’s comments on a robust
2Q exit order book with share gains in semis/autos, as well as one of its key
semis customers (Georg Fischer) reporting its semis-business orders
doubling YoY in 2Q.
Risk of value-destructive M&A following the potential sale of two less
attractive businesses. JPM view: We see logical industry consolidation as
key to improving fundamentals given rising competitive pressure—even
across a growing number of specialty products—from China/other EMs.
We therefore don’t view value-accretive consolidation and/or moatenhancing deals as problematic per se, though we are curious about
potential targets. Several Japanese diversified companies have niche
specialty polymers exposures that could be attractive to Syensqo,
particularly if they strengthen its foothold in the Japanese market.
Materials division valuation at an implied ~9x 2027E EV/EBITDA on
our SOTP—cheaper than the ~12x weighted-average of closest global
peers, but seen as expensive relative to the broader EU diversified
chemicals space.…
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer